The fund's investment objective is to achieve capital growth primarily through investment in UK equities.
Name | % Net Assets |
---|---|
Vodafone Group | 7.0% |
GlaxoSmithKline | 6.2% |
Royal Dutch Shell | 6.1% |
BG Group | 4.4% |
Unilever | 3.9% |
HSBC Holdings | 3.9% |
Rio Tinto | 3.4% |
BP | 3.2% |
Rolls-Royce Holdings | 3.0% |
AstraZeneca | 2.9% |
Key | % Net Assets |
---|---|
Vodafone Group | 7.0% |
GlaxoSmithKline | 6.2% |
Royal Dutch Shell | 6.1% |
BG Group | 4.4% |
Other | 76.3% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 18/03/2011 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.35% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research